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Fibronectin (FN) is comprised of multiple isoforms
arising from alternative splicing of a single gene tran-
script. One of the alternatively spliced segments, EDA, is
expressed prominently in embryonic development, ma-
lignant transformation, and wound healing. We showed
previously that EDA1 FN was more potent than EDA2
FN in promoting cell spreading and cell migration be-
cause of its enhanced binding affinity to integrin a5b1
(Manabe, R., Oh-e, N., Maeda, T., Fukuda, T., and Sekigu-
chi, K. (1997) J. Cell Biol. 139, 295–307). In this study, we
compared the cell cycle progression and its associated
signal transduction events induced by FN isoforms with
or without the EDA segment to examine whether the
EDA segment modulates the cell proliferative potential
of FN. We found that EDA1 FN was more potent than
EDA2 FN in inducing G1-S phase transition. Inclusion of
the EDA segment potentiated the ability of FN to induce
expression of cyclin D1, hyperphosphorylation of pRb,
and activation of mitogen-activated protein kinase ex-
tracellular signal regulated kinase 2 (ERK2). EDA1 FN
was also more potent than EDA2 FN in promoting FN-
mediated tyrosine phosphorylation of p130Cas, but not
focal adhesion kinase, which occurred in parallel with
the activation of ERK2, suggesting that p130Cas may be
involved in activation of ERK2. These results indicated
that alternative splicing at the EDA region is a novel
mechanism that promotes FN-induced cell cycle pro-
gression through up-regulation of integrin-mediated mi-
togenic signal transduction.
Fibronectins (FNs)1 are extracellular matrix glycoproteins
that play a role in cell adhesion and migration during embry-
onic development, wound healing, and tumor progression (1).
Proteolytic digestion of FN has revealed that FN has several
cell binding domains: the central cell binding domain (CCBD),
the COOH-terminal heparin binding domain (Hep2), and the
CS1 region within the type III connecting segment (IIICS) (2).
CCBD is the major cell-adhesive domain of FN and contains
the Arg-Gly-Asp (RGD) motif that is recognized by members of
the integrin family of cell adhesion receptors including a5b1,
avb1, avb3, avb5, avb6, aIIbb3, and a8b1 (3–6). There is
evidence that FN acts not only as a cell-adhesive substrate but
also transduces biochemical signals across the plasma mem-
brane via integrin receptors, thereby regulating cell prolifera-
tion, differentiation, and apoptosis (7–9). Interaction of FN
with integrins stimulates tyrosine phosphorylation of several
cellular proteins including FAK (10–12) and p130Cas (13–15)
and also stimulates activation of Src family protein tyrosine
kinases (7) and the extracellular signal-related kinases ERK1
and ERK2 (16–19). Furthermore, FN induces expression of
cyclin D1 and subsequent inactivation of pRb by hyperphos-
phorylation and thus mediates cell cycle progression through
the G1 phase (20).
FN contains three alternatively spliced segments: EDA,
EDB, and IIICS (21–24). The EDA and EDB segments are each
encoded by a single exon, and both comprise an intact type III
repeat (22). FNs expressed in fetal and tumor tissues contain a
greater percentage of EDA and EDB segments than those
expressed in normal adult tissues (25–29). Increased expres-
sion of FNs containing the EDA and/or EDB segments has also
been observed during wound healing (30). Because FNs con-
taining the EDA and/or EDB segments are highly expressed in
tissues that are populated with cells showing high proliferative
and migratory potential, it seems likely that FNs containing
these extra segments play an important role in promoting cell
proliferation and migration. Despite accumulated evidence for
regulated expression of EDA- and/or EDB-containing FNs in
vivo, the biological functions of these isoforms are poorly
understood (31).
Recently, we found that FN isoforms containing the EDA
segment (EDA1 FN) were more potent than those lacking the
EDA segment (EDA2 FN) in promoting cell adhesion and mi-
gration, irrespective of the presence or absence of the EDB
segment. The increased cell adhesion and migration were
caused by increased binding of EDA1 FN to integrin a5b1 (32).
In the present study, we investigated whether alternatively
spliced EDA and EDB segments regulate the potential of FNs
to promote cell proliferation. We found that insertion of the
EDA, but not EDB, segment potentiated the ability of FN to
promote cell cycle progression. The enhanced cell cycle progres-
sion was associated with increased tyrosine phosphorylation of
p130Cas, activation of ERK2, increased expression of cyclin D1,
and hyperphosphorylation of pRb. These results indicated that
alternative splicing in the EDA region regulates FN-mediated
extracellular signals and subsequent cell cycle progression via
modulation of binding affinity to integrin a5b1.
EXPERIMENTAL PROCEDURES
Purification of Recombinant FN Isoforms—Construction of the cDNA
expression vectors for three different full-length FN isoforms, EDA2/
EDB2 FN, EDA1/EDB2 FN, and EDA1/EDB1 FN, was described pre-
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viously (32). To construct the expression vector for EDA2/EDB1 FN, the
whole inserts of pHCF93B1 encoding Val527-Arg1449 including the EDB
segment (32) were excised by double digestion with SalI/BamHI and
ligated to SalI/BamHI-cleaved pAIFNC, which encodes a full-length FN
isoform lacking both EDA and EDB segments. The resulting cDNA
expression vector for EDA2/EDB1 FN was designated pAIFNBC. Re-
combinant FNs were expressed in CHO DG44 cells and purified from
the culture supernatants of the stable transfectants by gelatin-affinity
chromatography as described previously (32).
Cell Culture—CHO-K1 and CHO DG44 cells were obtained from the
Japanese Cancer Research Resources Bank (Tokyo, Japan) and Dr.
Lawrence Chasin (Columbia University), respectively. CHO-K1 cells
were grown in Ham’s F-12 medium supplemented with 10% FBS. CHO
DG44 cells deficient in dihydrofolate reductase activity were main-
tained in a-minimal essential medium containing ribonucleosides/de-
oxyribonucleosides and 10% FBS. Stable transfectants of CHO DG44
cells overexpressing recombinant FNs were maintained in a-minimal
essential medium without ribonucleosides/deoxyribonucleosides in the
presence of 10% FBS (for routine passage) or 1% FN-depleted FBS (for
large scale culture to purify recombinant proteins). All cells were main-
tained under a humidified 5% CO2 atmosphere at 37 °C.
Antibodies—Polyclonal antibodies against cyclin D1 (R-124), p130Cas
(N-17), and ERK2 (C-14), and horseradish peroxidase-conjugated anti-
phosphotyrosine mAb (PY20) were obtained from Santa Cruz Biotech-
nology, Inc. (Santa Cruz, CA). The mAb against pRb (G3-245) was
obtained from Pharmingen (San Diego). Anti-FAK mAb 2A7 was ob-
tained from Upstate Biotechnology (Lake Placid, NY). Horseradish
peroxidase-conjugated secondary antibodies against mouse or rabbit
IgG were from Cappel Worthington Biochemicals (Malvern, PA).
Cell Spreading Assay—Cell spreading assays were performed using
96-well microtiter plates coated with 5 mg/ml recombinant FNs and
blocked with 1% bovine serum albumin. Amounts of recombinant FNs
immobilized on plates were determined by enzyme-linked immunosor-
bent assay using anti-human FN antiserum or anti-FN mAbs as de-
scribed previously (32). CHO-K1 cells grown in Ham’s F-12 medium
containing 10% FBS were trypsin treated and washed with serum-free
medium. The cells were plated at a density of 3 3 104 cells/well in
serum-free medium and incubated at 37 °C for 40 min. Nonadherent
cells were removed by washing with serum-free medium, and attached
cells were fixed with 3.7% formaldehyde and then stained with Giemsa.
Cells adopting a well spread morphology (i.e. cells that had become
flattened with the long axis more than twice the diameter of the nu-
cleus) were counted/mm2.
Integrin-liposome Binding Assay—Integrins a5b1 and avb3 were
purified and reconstituted into liposomes as described previously (32).
Integrin-liposomes in TBS(1) (25 mM Tris-HCl, pH 7.5, 0.13 M NaCl, 1
mM CaCl2, and 1 mM MgCl2) containing 0.2% bovine serum albumin
were added to the wells of microtiter plates precoated with recombinant
FNs (20 mg/ml) and incubated for 6 h at room temperature. The wells
were washed with TBS(1), and bound liposomes were recovered in 1 N
NaOH. The radioactivity of bound liposomes was quantified using an
Aloka LSC-3500 scintillation counter (Aloka Co., Ltd., Tokyo).
Induction of G1-S Phase Transition in Synchronized Cells—CHO-K1
cells were grown to confluence and synchronized at G0 by serum star-
vation for 48 h in Ham’s F-12 supplemented with 0.2% FN-depleted
FBS, 50 mg/ml streptomycin, and 50 units/ml penicillin (starvation
medium) according to Orren et al. (33). The cells were dissociated with
phosphate-buffered saline containing 0.2% trypsin and 2 mM EDTA,
and trypsin treatment was stopped by adding soybean trypsin inhibitor
(1 mg/ml). The cells were washed with serum-free medium, incubated in
suspension in starvation medium for 90 min at 37 °C, and seeded on
plates that had been precoated with 5 mg/ml recombinant FNs or 20
mg/ml poly-L-lysine and then blocked with 1% bovine serum albumin.
The amounts of immobilized recombinant FNs on the plates were de-
termined by enzyme-linked immunosorbent assay using anti-human
FN antiserum to confirm the equality of adsorbed FNs.
Determination of S Phase Entry—Quiescent cells were kept in sus-
pension for 90 min and then plated at a density of 2 3 104 cells/well in
starvation medium. [3H]Thymidine (5 mCi/ml) was added 12–24 h after
cell plating. The cells were washed three times with serum-free medium
at the indicated time points, fixed with ice-cold 10% trichloroacetic acid
for 1 h, and washed once with 10% trichloroacetic acid. The acid-
insoluble precipitates were dissolved with 0.1% SDS and 0.2 N NaOH,
neutralized with 0.2 N HCl, and transferred to vials containing scintil-
lation fluid. Radioactivities in the precipitates were determined with an
Aloka LSC-3500 scintillation counter. To determine the percentage of
cells entering S phase, bromodeoxyuridine was added to the cultures
12–24 h after plating, and the cells were incubated with anti-bromode-
oxyuridine mAb followed by visualization of bound mAb with 3,39-
diaminobenzidine tetrahydrochloride according to the manufacturer’s
instructions (Amersham Pharmacia Biotech).
Immunoprecipitation and Immunoblotting—Quiescent cells cultured
on the substratum were extracted in lysis buffer (1% Nonidet P-40, 20
mM Tris-HCl, pH 7.5, 10 mM EDTA, 40 mM b-glycerophosphate, 2 mM
orthovanadate, 0.5 mM sodium fluoride, 20 mg/ml leupeptin, 5 mg/ml
aprotinin, 1 mM phenylmethylsulfonyl fluoride). The cell lysates were
clarified by centrifugation at 14,000 3 g for 10 min at 4 °C, and protein
concentration was determined using a DC protein assay kit (Bio-Rad).
The whole lysates were boiled in SDS-sample buffer (8% SDS, 100 mM
dithiothreitol, 266 mM Tris, pH 6.8, 40 mM EDTA), and equal amounts
of protein were subjected to SDS-polyacrylamide gel electrophoresis
with 8, 12, or 12.5% gels for detection of tyrosine-phosphorylated pro-
teins and pRb (8%), cyclin D1 (12%), and ERK2 (12.5%). Proteins were
detected immunologically after electrotransfer onto nitrocellulose mem-
branes as described (32).
For immunoprecipitation of FAK, cell lysates were incubated with
protein A-conjugated anti-FAK mAb 2A7 for 5 h. For immunoprecipi-
tation of p130Cas, cell lysates were incubated with anti-p130Cas antibody
for 1 h followed by incubation with protein G-Sepharose (Amersham
Pharmacia Biotech) for 4 h. The immune complexes were precipitated
by brief centrifugation and washed four times with lysis buffer. The
immunoprecipitates were separated on 8% polyacrylamide gels to de-
termine the levels of tyrosine phosphorylation and the amounts of
precipitated proteins as described above.
RESULTS
EDA but Not EDB Regulates Cell Adhesive Functions of
FN—We showed previously that the presence or absence of the
EDB segment did not affect the ability of EDA1 FN isoforms to
promote cell adhesion and spreading (32), although we could
not exclude the possibility that inclusion of the EDB segment
alone might potentiate the cell-adhesive activity of FN. To
explore this possibility, we produced a recombinant FN isoform
containing the EDB but not the EDA segment (designated
rFN(BC); see Fig. 1) and compared its cell attachment and
spreading activities with those of rFN(C), rFN(AC) and rFN-
(BAC). CHO-K1 cells were used in these assays because they
have long been used as a standard model in cell cycle analysis
and are more easily synchronized at the G0 state than HT1080
cells, which were used in the previous study (32). Significant
differences were observed in both cell attachment and spread-
ing among the four different FN isoforms, EDA1 FNs (i.e.
rFN(AC) and rFN(BAC)) being more potent in promoting cell
attachment than EDA2 FNs (i.e. rFN(C) and rFN(BC)) (Fig.
2A). EDA1 FNs were also more than twice as effective as EDA2
FNs in inducing cell spreading (Fig. 2B). No significant differ-
ences were observed in cell spreading activity between
rFN(AC) and rFN(BAC) or between rFN(C) and rFN(BC) (Fig.
2B), indicating that the EDB segment is not involved in regu-
lation of the cell-adhesive activity of FN. Because CHO-K1 cells
adhere to FN-coated substrates predominantly via integrin
a5b1 (34) and the increased cell-adhesive activity of EDA1 FNs
is the result of enhanced binding of CCBD to integrin a5b1
(32), the integrin binding activity of EDB1 FN was compared
with that of EDB2 FN. There were no significant differences in
integrin a5b1 binding between rFN(C) and rFN(BC), although
rFN(AC) was more than twice as active as rFN(C) and rFN(BC)
in integrin a5b1 binding (Fig. 3). These results support the
previous conclusion that the cell-adhesive functions of FN are
specifically regulated by insertion of the EDA but not the EDB
segment.
EDA1 FN Is More Potent than EDA2 FN in Promoting Cell
Cycle Progression—The in vivo expression patterns of EDA1
FN suggested a potential role of EDA1 FN in cell proliferation
(31). To investigate whether insertion of the EDA and/or EDB
segment affects the ability of FN to promote cell proliferation,
CHO-K1 cells were synchronized at the G0 phase by serum
starvation, incubated in suspension for 90 min, and replated on
substrates precoated with different FN isoforms to stimulate






















the cells to reenter the cell cycle. To confirm that the effects of
FN isoforms on cell proliferation were primarily mediated via
integrins, the cells were also plated on the substrate coated
with poly-L-lysine, which mediates integrin-independent cell
adhesion. All recombinant FNs significantly promoted entry
into S phase when compared with poly-L-lysine (Fig. 4). The
levels of DNA synthesis were different among the FN isoforms;
rFN(AC) and rFN(BAC) were more potent than rFN(C) and
rFN(BC) in inducing DNA synthesis. No significant differences
were observed between rFN(AC) and rFN(BAC) or between
rFN(C) and rFN(BC). Labeling of cells with bromodeoxyuridine
showed that more than 70% of the plated cells entered the S
phase by 24 h after replating onto the FN-coated substrata
(data not shown). These results indicated that EDA1 FN has a
greater potential than EDA2 FN to induce cell proliferation
irrespective of the presence or absence of the EDB segment.
EDA Segment Up-regulates Cell Cycle-associated Signal
Transduction—It has been shown that pRb plays a key role in
the G1-S phase transition. Inactivation of pRb by hyperphos-
phorylation occurs at the restriction point in G1 as the cell
enters the S phase (35). We investigated whether the presence
or absence of the EDA segment could modulate FN-induced
phosphorylation of pRb. Quiescent cells were trypsin treated,
held in suspension to reset anchorage-dependent signals, and
replated onto dishes coated with rFN(C), rFN(AC) or poly-L-
lysine. Hypo- and hyperphosphorylated forms of pRb were dis-
tinguished by the difference in their mobility on SDS-polyacryl-
amide gel electrophoresis. Hyperphosphorylation of pRb was
induced on the substrates coated with rFN(C) and rFN(AC)
compared with those with poly-L-lysine (Fig. 5, upper panel).
The level of pRb hyperphosphorylation was higher with cells
plated on rFN(AC) than on rFN(C) through 16–24 h after plat-
ing, indicating that the increased cell cycle progression driven by
EDA1 FN was associated with the increased hyperphosphoryla-
tion of pRb. Although pRb hyperphosphorylation was detectable
even on poly-L-lysine upon prolonged incubation, this could be
the result of deposition of endogenous FN by CHO cells.
FIG. 1. Structure of recombinant
FNs. Modular structures of recombinant
FNs are shown schematically on the basis
of internally homologous modules termed
types I, II, and III. The EDA and EDB
segments are shown by filled rectangles,
and the IIICS segment is shown by a
hatched oval. All recombinant FNs con-
tain the complete IIICS sequence of 120
amino acids. Functional domains that in-
teract with heparin (Hep1, Hep2), fibrin
(Fib1, Fib2), bacteria, collagen, and inte-
grin a5b1 are indicated above the figures.
FIG. 2. Attachment and spreading
of CHO cells on recombinant FN-
coated substrata. Panel A, CHO cells
(3 3 104) were seeded on 96-well microti-
ter plates coated with 5 mg/ml of different
FN isoforms and incubated for 40 min at
37 °C. The cells were rinsed, fixed, and
stained with Giemsa. Bar, 100 mm. Panel
B, spreading of CHO cells was quantified
as described under “Experimental Proce-
dures.” The S.D. of multiple determina-
tions (n 5 3) are indicated at the top of the
bars.
FIG. 3. Binding of integrin a5b1 to recombinant FNs. Integrin
a5b1 was purified from human placenta and reconstituted in phos-
phatidylcholine liposomes as described under “Experimental Proce-
dures.” The integrin a5b1-liposomes were added to microtiter plates
precoated with 20 mg/ml of different FN isoforms and incubated for 6 h
at room temperature. Quantities of bound integrin a5b1-liposomes are
expressed as percentages of the total input radioactivity after subtrac-
tion of the radioactivity bound to plates coated only with bovine serum
albumin. Each bar represents the mean S.D. (n 5 6).






















pRb has been shown to be phosphorylated by cyclin D1zcdk4/6
complexes, with concomitant accumulation of cyclin D1 during
the G1 phase (35). Therefore, we examined whether the level of
expression of cyclin D1 was also modulated by the EDA seg-
ment upon cell adhesion onto FN-coated substrates. When cells
were plated onto substrates coated with recombinant FNs with
or without the EDA segment, the expression of cyclin D1 was
significantly induced by 24 h after replating, although no ob-
vious induction of cyclin D1 expression was observed on the
poly-L-lysine-coated substrate (Fig. 5, lower panel). The expres-
sion of cyclin D1 was more pronounced with cells plated onto
rFN(AC) than onto rFN(C) with a time course profile similar to
that of pRb hyperphosphorylation. These results indicated that
expression of cyclin D1 and phosphorylation of pRb were coor-
dinately regulated by the EDA segment upon cell adhesion to
FN-coated substrates.
EDA Segment Enhances FN-dependent MAP Kinase Activa-
tion—Because activation of MAP kinase has been shown to
induce expression of cyclin D1 and subsequent hyperphospho-
rylation of pRb (36), we investigated whether ERK2 MAP ki-
nase was stimulated differently by EDA1 and EDA2 FNs.
When quiescent cells were detached and either held in suspen-
sion or replated on dishes coated with rFN(C), rFN(AC), or
poly-L-lysine, the activated form of ERK2 was detectable as
early as 10 min after replating and persisted for over 60 min
(Fig. 6). In contrast, no significant activation was observed in
cells kept in suspension or replated on the substratum coated
with poly-L-lysine. Activation of ERK2 was more prominent on
surfaces coated with rFN(AC) than on those coated with
rFN(C), indicating that the EDA segment potentiates the abil-
ity of FN to activate MAP kinases via integrin-dependent sig-
naling and thereby promotes cell cycle progression.
EDA Increases FN-induced Tyrosine Phosphorylation of
p130Cas—Protein tyrosine phosphorylation triggered by inte-
grin-mediated cell-matrix interaction has been shown to be
caused by activation of protein tyrosine kinases including the
Src family kinases, FAK and FAK-related kinases (7). These
kinases phosphorylate tyrosine residues of their specific sub-
strate proteins, providing binding sites for SH2-containing
molecules that are involved in cell proliferation (7). We exam-
ined whether the EDA segment modulates the ability of FNs to
stimulate tyrosine phosphorylation of cellular proteins. In par-
allel with the analysis of FN-dependent activation of ERK2,
quiescent cells were kept in suspension or replated on dishes
precoated with rFN(C), rFN(AC), or poly-L-lysine and incu-
bated for different periods. As shown in Fig. 7A, proteins mi-
grating at positions corresponding to 150, 130, and 80–60 kDa
were tyrosine phosphorylated irrespective of the type of sub-
strate. Among these, tyrosine phosphorylation of the 130-kDa
protein was significantly induced in cells plated on substrates
coated with recombinant FNs but not in cells either plated on
poly-L-lysine-coated substrates or kept in suspension. The ki-
netics of tyrosine phosphorylation of the 130-kDa protein were
similar to those of ERK2 activation (Fig. 6). The 130-kDa
protein was tyrosine-phosphorylated at 10 min after replating
on FN-coated surfaces, and the levels of tyrosine phosphoryla-
tion persisted for more than 60 min. The 130-kDa protein was
more prominently tyrosine-phosphorylated in cells on rFN(AC)
than those plated on rFN(C).
Cell adhesion to FN-coated substrates has been shown to
induce tyrosine phosphorylation of p125FAK (10–12) and
p130Cas (13–15). Immunoprecipitation with anti-FAK and anti-
p130Cas antibodies showed that p130Cas was phosphorylated in
CHO-K1 cells plated onto FN-coated surfaces, although no
significant tyrosine phosphorylation was observed with FAK in
the same cells (Fig. 7B, upper panel). These results indicated
that the tyrosine-phosphorylated 130-kDa protein was p130Cas
but not FAK. Tyrosine phosphorylation of p130Cas was more
pronounced on the substrates coated with rFN(AC) than on
those coated with rFN(C). The enhanced phosphorylation of the
FIG. 4. Induction of DNA synthesis upon adhesion of cells onto
recombinant FN-coated substrata. Quiescent CHO cells were re-
plated onto wells precoated with 5 mg/ml rFN(C), rFN(BC), rFN(AC),
rFN(BAC), or 20 mg/ml poly-L-lysine (PLL) in starvation medium.
[3H]Thymidine was added to the wells 12 h after replating, and the cells
were cultured for the indicated periods. S phase entry was quantified by
measuring [3H]thymidine incorporation into DNA as described under
“Experimental Procedures.” Each bar represents the mean S.D. (n 5 6).
FIG. 5. pRb phosphorylation and cyclin D1 accumulation in
response to cell adhesion onto recombinant FN-coated sub-
strata. Quiescent CHO cells were seeded onto substrates coated with 5
mg/ml rFN(C) or rFN(AC) or 20 mg/ml poly-L-lysine (PLL), or they were
kept in suspension in starvation medium for varying periods as indi-
cated. Cells were then solubilized in Nonidet P-40 lysis buffer, and
equal amounts of whole cell lysates were subjected to SDS-polyacryl-
amide gel electrophoresis. Protein levels of pRb (upper panel) and cyclin
D1 (lower panel) were detected by Western blotting with antibodies
specific for pRb or cyclin D1 after electrotransfer onto nitrocellulose
membranes. The positions of hyper- and hypophosphorylated pRbs are
indicated as ppRb and pRb, respectively. The reproducibility of the
results was confirmed in three separate experiments.
FIG. 6. MAP kinase activation induced by recombinant FNs.
Quiescent cells were either held in suspension or plated on substrates
coated with 5 mg/ml rFN(C) or rFN(AC) or 20 mg/ml poly-L-lysine (PLL)
in starvation medium for various times. Cells were lysed, and MAP
kinase activity was analyzed by a band shift assay. The phosphorylated,
activated forms of ERK2 (pp42) display more reduced electrophoretic
mobility than the unphosphorylated, nonactivated forms of ERK2 (p42).
The reproducibility of the results was confirmed in three separate
experiments.






















130-kDa protein was not the result of an increase in p130Cas
expression because the amount of immunoprecipitated p130Cas
was decreased rather slightly on rFN(AC) than that on rFN(C)
(Fig. 7B, bottom panel). Although we could not exclude the pos-
sibility that FAK was tyrosine-phosphorylated at levels below the
limits of detection, it is likely that p130Cas is the main target of
protein tyrosine kinases activated by integrin-mediated adhe-
sion onto FN-coated substrates and therefore is involved in
activation of ERK2 and subsequent cell cycle progression.
DISCUSSION
Regulation of FN-mediated Signal Transduction by the EDA
Segment—It has been shown that the EDA segment is included
in FN species expressed in embryonic tissues, but is spliced out
of the molecule as embryonic development proceeds (28, 31). In
adults, EDA1 FN reappears at sites of tissue injury and in-
flammation (30, 38). Despite the close association of the expres-
sion of EDA1 FN with tissues populated with cells showing
high proliferative potential, the physiological significance of
this phenomenon is not known.
In this study, we found that EDA1 FN was more potent than
EDA2 FN in inducing G1-S phase transition. The increased
ability of EDA1 FN to induce G1-S phase transition was closely
associated with enhanced ERK2 activation, cyclin D1 expres-
sion, and pRb phosphorylation. Given that EDA1 FN is more
potent than EDA2 FN in promoting cell adhesion through
enhanced binding to integrin a5b1 (32) and that ligand ligation
of integrin a5b1 promotes DNA synthesis through activation of
intercellular signal transduction pathways involving ERK2,
cyclin D1, and pRb (1, 20), it is conceivable that inclusion of the
EDA segment up-regulates FN-dependent mitogenic signal
transduction through increased binding of FN to integrin a5b1.
Because EDA1 FN is expressed preferentially in embryonic
and tumor tissues, alternative splicing at the EDA region of FN
may be instrumental in supporting the high proliferative po-
tential of cells in these tissues.
FN contains two major integrin binding regions: CCBD and
CS-1. CCBD is recognized by integrin a5b1 and av-containing
integrins, whereas CS-1 is recognized by integrin a4b1. Be-
sides the distinct binding specificities, the integrin binding
activities of these two regions are regulated differently at the
level of RNA splicing. Thus, the CS-1 region itself is excluded
from the FN molecule by alternative splicing (39–41), regulat-
ing its cell adhesive activity in an all-or-none manner. In con-
trast, CCBD is encoded by constitutive exons, and its cell
adhesive activity is regulated by the alternatively spliced EDA
segment in a range of 2;3-fold increments. The difference in
the mode of regulation of their activities by alternative splicing
appears to reflect the physiological roles of these cell adhesive
regions. Integrin a5b1, the major receptor for CCBD, is ex-
pressed on a wide variety of cell types and plays a central role
in adhesion-dependent signaling events involved in prolifera-
tion, migration, and survival of cells (1, 9). The interaction of
integrin a5b1 with CCBD may provide housekeeping signals
that need to be maintained strictly at the minimal level re-
quired for cell survival. In contrast, integrin a4b1, the specific
receptor for CS-1, is expressed on restricted cell types such as
lymphocytes (39, 42) and elicits a cell type-specific proliferation
signal (43). All-or-none regulation of CS-1 activity by alterna-
tive splicing may be suitable for such an auxiliary signal,
leaving the basal survival signal from CCBD uncompromised.
The interaction of cells with FN is regulated not only by the
alternative splicing at the EDA region but also by the affinity
states of integrin a5b1. Integrins exist at different affinity
states ranging from inactive to fully activated forms (44). The
affinity states of integrins are modulated by cellular stimula-
tion by chemoattractants (44) and interaction with membrane-
associated proteins such as IAP (integrin-associated protein)
(45). Modulation of the ligand binding affinity of integrin a5b1
has been shown to affect FN-dependent cell proliferation (46)
and differentiation (47) by modulation of integrin a5b1-medi-
ated signal transduction. It is conceivable, therefore, that al-
ternative splicing of FN and affinity modulation of integrin
a5b1 coordinately regulate the integrin-mediated, extracellu-
lar signals required for proliferation, differentiation, and sur-
vival of cells.
Role of p130Cas in FN-mediated Signal Transduction—We
found that cell adhesion to FN-coated substrata activates
ERK2 without significant tyrosine phosphorylation of FAK.
Although there is some evidence suggesting that FAK can
activate the ERK signaling pathway in response to cell adhe-
sion (16, 17, 19), it is unclear whether FAK plays a physiolog-
ical role in the ERK signaling pathway. In fact, recent studies
FIG. 7. Tyrosine phosphorylation of p130Cas and FAK upon cell adhesion onto recombinant FNs. Panel A, quiescent cells were either
held in suspension or plated on substrates coated with 5 mg/ml rFN(C) or rFN(AC) or 20 mg/ml poly-L-lysine (PLL) in starvation medium for various
times. Whole cell lysates were prepared, and tyrosine phosphorylation of cellular proteins was analyzed by immunoblotting with anti-phospho-
tyrosine antibody. The positions of molecular weight marker proteins are indicated in the left margin. Panel B, whole cell lysates prepared 30 min
after replating were immunoprecipitated with anti-p130Cas or anti-FAK antibody. The immunoprecipitates were subjected to immunoblotting with
antibodies against phosphotyrosine (upper), FAK (middle), and p130Cas (bottom). The reproducibility of the results was confirmed in two separate
experiments.






















have shown that the activation of ERK in response to integrin
ligation is mediated by the adaptor protein Shc independently
of FAK (48). In support of this observation, introduction of a
dominant-negative version of FAK did not impair the ERK
activation elicited by cell adhesion to FN (49). Our results also
showed that p130Cas, but not FAK, was prominently tyrosine-
phosphorylated in response to cell adhesion onto FN-coated
substrata with kinetics similar to those of ERK2 activation.
Although the precise molecular mechanisms of p130Cas-
dependent activation of ERK remain to be defined, tyrosine
phosphorylation of p130Cas was suggested to be involved in
ERK activation by the following observations. First, overex-
pression of p130Cas or FN-stimulated tyrosine phosphorylation
of p130Cas promotes the SH2-mediated binding of the adaptor
proteins Crk and/or Nck to p130Cas and subsequent association
of Crk and/or Nck with the GDP-GTP exchange protein Sos,
which could result in Ras activation (50, 51). Second, overex-
pression of protein tyrosine phosphatase 1B, which can also
associate with p130Cas, resulted in dephosphorylation p130Cas
and inhibition of ERK activation, whereas a protein tyrosine
phosphatase 1B mutant unable to bind p130Cas failed to de-
phosphorylate p130Cas and therefore failed to inhibit ERK ac-
tivation (52). Although these observations seem to support the
involvement of p130Cas in ERK activation, further studies are
required to define the role of tyrosine phosphorylation of p130Cas
in EDA-dependent enhancement of cell cycle progression.
Adhesive Function of FN Is Independent of the EDB Seg-
ment—Our results showed that the abilities of rFN(BC) to
promote cell adhesion, integrin a5b1 binding, and cell cycle
progression were the same as those of rFN(C) and were signif-
icantly lower than those of rFN(AC), excluding the possibility
that inclusion of the EDB segment alone might potentiate the
adhesive activity of FN. Adhesive functions of FN are therefore
regulated exclusively by alternative splicing at EDA but not
EDB. Based on the three-dimensional structure of a recombi-
nant FN fragment consisting of III7–III10 modules (53), we
proposed that insertion of the EDA segment alters the global
conformation of the FN molecule through rotating the NH2-
terminal portion of the FN polypeptide relative to the COOH
terminus, thereby resulting in the enhanced binding of EDA1
FN to integrin a5b1 because of an increased exposure of the
RGD motif in III10 module and/or local unfolding of the module
(32). Failure of the EDB segment to substitute for EDA in
altering the global conformation of the FN so as to increase the
binding affinity to integrin a5b1 indicates that the conforma-
tional activation of FN by insertion of an extra type III module
is dependent on the position and/or sequence of the inserted
module, making the EDA segment most suited for modulation
of the binding affinity to integrin a5b1.
Although the presence or absence of the EDB segment did
not affect the cell adhesive activity of FNs, the EDB segment
may modulate other biological functions of FN. Expression of
EDB1 FN in vivo is more restricted than that of EDA1 FN (28),
suggesting that the EDB segment may have an important
function only in highly specific situations such as angiogenesis
(54) and lung development (55). Regulated in vivo expression of
recombinant FN isoforms differing with respect to the presence
or absence of the EDA and EDB segments should provide
insight into the physiological and pathological roles of the
alternatively spliced segments during development, tumori-
genesis, and inflammatory processes.
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